Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 May 19;29(8):1577–1585. doi: 10.1158/1055-9965.EPI-20-0378

Figure 1.

Figure 1.

Overall survival curves among pancreatic cancer cases in the nested case-control study for the the CpG in PIM-1 promoter. Results for this CpG were consistent in the nested case-control study and PanGenEU. Curves are adjusted age, date of blood draw, time between blood draw and diagnosis, smoking, cohorts, and immune cell proportions.